Revvity, Inc. RVTY announced the launch of Signals BioDesign, a cloud-based molecular cloning platform, under its Revvity ...

Ottawa, Nov. 12, 2025 (GLOBE NEWSWIRE) -- The global molecular cloning market size was valued at USD 5.25 billion in 2024 and is predicted to hit around USD 8.89 billion by 2034, rising at a 5.4% CAGR ...

Molecular cloning relies on two key components to construct recombinant DNA: 1) a DNA vector and 2) one or more DNA fragments containing the gene(s) of interest (GOI). To produce a GOI fragment, DNA ...

Revvity, Inc. (NYSE: RVTY) announced that its Revvity Signals Software business is launching Signals BioDesignTM, a ...

In this Teach Me in 10, Dr. Larry Mulcahy, Product Manager of Biologics at Revvity, explains how Signals BioDesign software ...

The Gibson Assembly® method has quickly become an invaluable tool for molecular cloning workflows due to its flexibility and efficiency. It allows for the cloning of multiple fragments directly into ...